1. Buckman R., Wiltshaw E.: Progressive Multifocal
Leucoencephalopathy Successfully Treated with Cytosine Arabinoside.
Br J Haematol; 34 (1): 153-155, 1976.
2. Buckman R., Dearnaley D.: Separation of
breast cancer cells in bone marrow. Br. J. Cancer, 1981; 44:299.
3. Buckman R., Cuzick J., Galton D.A.: Long-term
Survival in Myelomatosis. A Report To The MRC Working Party
on Leukaemia in Adults. Br J Haematol; 52 (4): 589-599, 1982.
4. Buckman R.: Malignancy - Tumour Markers
in Clinical Practice. Brit J Hospl Med; 8 (5): 355-360, 1982.
5. Coombes R.C., Dearnaley D.P., Buckman R.,
Jones J.M., Ormerod M.G., Sloane J.P., Powles T.J., Gazet J.C.,
Ford H.T., Neville A.M.: Detection of Bone Metastases in Patients
With Breast Cancer. Invasion Metastasis; 2 (3): 177-184, 1982.
6. Buckman R., McIlhinney R.A.J., Shepherd
V., Patel S., Coombes R.C., Neville A.M.: The Elimination of
Carcinoma Cells From Human Bone Marrow. Lancet, 2 (8313): 1428-1430,
1982.
7. Stuart-Harris R., Buckman R., Starke I.,
Wiltshaw E.: Chlorpromazine, Placebo and Droperidol in the Treatment
of Nausea and Vomiting Associated with Cisplatin Therapy. Postgrad.
Med. J.; 59 (694): 500-503, 1983.
8. Buckman R., Redding W.H., Dearnaley D.P,
Smith S., Coombes R.C.: Evaluation Of A Rosetting Method In
Detection Of Breast Cancer Cells. Br. J. Cancer, 49 (1): 103-106,
1984.
9. Buckman R., Coombes R.C., Dearnaley D.P.,
Gore M., Gusterson B., Neville A.M.: Breast Cancer: Some Clinical
Uses of Biological Markers. Cancer Invest Manage; 1: 109-126,
1984.
10. Buckman R., Coombes R.C., Forester A.J.;
Shepherd V., McIlhinney R.A.J., Neville A.M.: Elimination of
Malignant Cells From Bone Marrow In Autologous Rescue (Meeting
Abstract). Proc Ann Meet Am Assoc Cancer Res; 25: 156, 1984.
11. Buckman R.: Breaking bad news: Why is it
still so difficult? BMJ (26th May) 288: 1597-1599, 1984.
12. Souhami R.L., Finn G., Gregory W.M., Birkhead
B.G., Buckman R., Edwards D., Goldstone A.H., Harper P.G., Spiro
S.G., Tobias J.S., Geddes D.: High-Dose Cyclophosphamide in
Small-Cell Carcinoma of the Lung. Journal of Clinical Oncology,
3(7) 958-963, 1985.
13. Crawford S.M., Buckman R.: Nabilone and
Metoclopramide in the Treatment of Nausea and Vomiting due to
Cisplatinum: A Double Blind Study. Med. Oncol. & Tumor Pharmacother,
3(1): 39-42, 1986.
14. Coombes R.C., Buckman R., Forrester J.A.
et al: In Vitro and in Vivo Effects of a Monoclonal Antibody-Toxin
Conjugate for Use in Autologous Bone Marrow Transplantation
for Patients with Breast Cancer. Cancer Research 46 (8): 4217-4220,
August 1986.
15. Maher E.R., Buckman R.: Intrapericardial
Installation of Bleomycin in Malignant Pericardial Effusion.
Am Heart J; 111 (3): 613-614, 1986.
16. Wodinsky H.B, DeAngelis C., Rusthoven J.J.,
Kerr I.G., Sutherland D., Iscoe N., Buckman R., Kornijenko M.:
Re-Evaluating The Cost Of OutPatient Cancer Chemotherapy. CMAJ;
137 (10): 903-906, 1987.
17. Shaw P., Buckman R., Law J., Baumal R.,
Marks A.: Reactivity of Tumor Cells in Malignant Effusions with
a Panel of Monoclonal and Polyclonal Antibodies. Tumour Biol
9 (No. 2-3): 101-109, 1988.
18. Marks A., Buckman R., Kwok C.-S. et al.:
Preclinical and clinical studies of radioiodinated monoclonal
antibody 2G3 for therapy of intraperitoneal effusions associated
with carcinoma of breast and ovary. Antibody, Immunoconjugates
and Radiopharmaceuticals, 2 (2): 83-92, 1989.
19. Buckman R.: Communicating with cancer patients.
The Practitioner 233: 1393-1396, 1989.
20. Buckman R, Pritchard KI, Sutherland DJA,
MacKenzie RG, Ackerman I, Doherty M, Catton P: Adjuvant therapy
for node-negative breast cancer. (Letter) New Engl J Med 321:
471, 1989.
21. Buckman R., Senn J.: Eligibity for CPR:
Is every death a cardiac arrest? CMAJ, Vol. 140, pp. 1068-1069,
May 1, 1989.
22. Buckman R., Doan B: Enhancing the quality
of life of the cancer patient and the oncologist: Referrals
to the psychologist - who and when? In Press, Cancer In Ontario
1991, Ontario Cancer Treatment and Research Foundation.
23. MacCormick I., Kerr J., Jeffrey R., Buckman
R., Trott M., MacDonald M.: 5-Florouracil (FU) & Folinic
Acid (FA) as salvage therapy in heavily pre-treated ovarian
cancer (OV CA). Abstract: Program/Proceedings ASCO Vol. 10 March
1991, Houston, Texas.
24. Simpson M., Buckman R., Stewart M., Maguire
P., Lipkin M., Novack D., Till J.: Doctor-Patient Conference:
The Toronto Consensus Statement. BMJ vol 303 (6814):1385-1387,
Nov 30, 1991.
25. Stewart D.J., Eisenhauer E.A., Skillings
J., Pritchard K.I., Buckman R., Vandenberg T., Verma S., Aitken
S., Norris B.: Phase II study of oral menogaril as first line
chemotherapy for advanced breast cancer: A National Institute
of Canada Clinical Trials Group Study. Annals of Oncology 3:
201-204, 1992.
26. Buckman R., DeAngelis C., Shaw P., Covens
A., Osborne R., Kerr I., Reed R., Michaels H., Woo M., Reilly
R., Law J., Baumal R., Groves E., Marks A.: Intraperitoneal
therapy of malignant ascites associated with carcinoma of the
ovary and breast using radioiodinated monoclonal antibody 2G3.
Gynecologic Oncology, 47(1): 102-9, 1992.
27. Buckman R. Whos for CPR? Journal of the
Royal College of Physicians of London. August 1992.
28. Vandenberg T.A., Pritchard K.I., Eisenhauer
E.A., Trudeau, M.E., Norris B.D., Lopez P., Verma S.S., Buckman
R.A., Muldal, A.: Phase II study of weekly edatrexate (10-Edam)
as first line chemotherapy for metastatic breast cancer. J.
Clin Oncol, March 1993
29. Garg A., Buckman R., Kason Y Teaching medical
students how to break bad news CMAJ 1997 56: 408 - 414
30. Frankel A., Buckman R., Kerbel R Abrogation
of Taxol-induced G2M-arrest and apoptosis and human ovarian
cancer cells grown as multicellular tumor spheroids Cancer Research
1997 June 2388-93
31. Buckman R. Talking to patients about
cancer. Bmj 1996;313(7059):699-700.
32. Buckman R. One example is worth a million
words. Can Fam Physician 2000;46:1003-4, 1011-3.
33. Baile WF, Buckman R, Lenzi R, Glober
G, Beale EA, Kudelka AP. SPIKES-A six-step protocol for delivering
bad news: application to the patient with cancer. Oncologist
2000;5(4):302-11.
34. Buckman R. Communication skills in palliative
care: a practical guide. Neurol Clin 2001;19(4):989-1004.
35. Daly MB, Barsevick A, Miller SM, Buckman
R, Costalas J, Montgomery S, et al. Communicating genetic test
results to the family: a six-step, skills-building strategy.
Fam Community Health 2001;24(3):13-26.
36. Baile WF, Lenzi R, Parker PA, Buckman
R, Cohen L. Oncologists' attitudes toward and practices in giving
bad news: an exploratory study. J Clin Oncol 2002;20(8):2189-96.
1. Gore M., Buckman R., Stern G.: Intrathecal cytarabine in multiple sclerosis. Lancet, 1979; ii:202.
2. Buckman R.: Book Review; The Dread Disease: Cancer and Modern American Culture, by James T. Patterson. CMAJ, Vol. 138, June 15, 1988, pp. 1121 1122.
3. Buckman R., Senn J.: Eligibility for CPR: Is Every Death A Cardiac Arrest?. CMAJ, Vol. 140, May 1, 1989.
4. Saunders C., Baines M.: Living with dying: The management of terminal disease. Foreward written by Buckman R.- A foreword for people who are not experts in palliative care. pp. v-vi, 1989.
5. Buckman R: Book Review; Awkward Questions: Introducing New Treatments for Cancer: Practical, Ethical and Legal Problems: Ed CJ Williams, pp. 492 - for the British Medical Journal, August 1992.
6. Doctor-Patient Communication: the Toronto consensus statement. Simpson M, Buckman R Stewart M, Maguire P, Lipkin M et al BMJ 1991 303: 1385-7
7. Buckman R: Who's for CPR? J Roy Coll Phys London 26: 461-2, 1992.
8. Buckman R, Lewith G. What does homeopathy do - and how? BMJ 309: 103-6, 1994.
9. Buckman R (Editorial) Talking to Patients About Cancer BMJ 1996 313:699-670
10. Buckman R, Tozer R Metastatic breast cancer responsive to low dose continuous chemotherapy combined with low molecular weight heparin and low-dose prednisone: threrapy with negligible toxicity and anti-angiogenic potential Chronicle of Cancer Therapy Winter 2003 18-19
11. Breaking Bad News – Yes, But How? (leter) Buckman R Baile W J Clin Oncol 2007
